Bandaram Pharma Packtech Limited (BOM:524602)
India · Delayed Price · Currency is INR 39.90
+1.00 (2.57%)
At close: Jul 28, 2025
Lumos Pharma Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Cash & Equivalents | 1.19 | 0.42 | 1.57 | 20.83 | 0 | Upgrade |
Cash & Short-Term Investments | 1.19 | 0.42 | 1.57 | 20.83 | 0 | Upgrade |
Cash Growth | 181.71% | -73.17% | -92.47% | 1409417.86% | -95.52% | Upgrade |
Accounts Receivable | 187.56 | 145.21 | 66.21 | - | - | Upgrade |
Other Receivables | 32.4 | 12.45 | 8.67 | - | 0.02 | Upgrade |
Receivables | 222.57 | 157.67 | 74.87 | - | 7.61 | Upgrade |
Inventory | 85.05 | 64.68 | 49.7 | - | - | Upgrade |
Other Current Assets | - | 37.88 | 24.45 | 9.17 | 0.04 | Upgrade |
Total Current Assets | 308.81 | 260.64 | 150.59 | 30 | 7.65 | Upgrade |
Property, Plant & Equipment | 39.51 | 44.84 | 50.35 | - | 1.01 | Upgrade |
Long-Term Investments | 14 | 14 | - | - | - | Upgrade |
Other Intangible Assets | - | - | - | - | 0.04 | Upgrade |
Long-Term Deferred Tax Assets | 0.01 | - | - | - | - | Upgrade |
Long-Term Deferred Charges | - | 0.12 | 0.15 | - | - | Upgrade |
Other Long-Term Assets | 26.85 | 0.97 | 0.65 | - | - | Upgrade |
Total Assets | 389.18 | 320.57 | 201.74 | 30 | 12.61 | Upgrade |
Accounts Payable | 43.57 | 41.18 | 2.36 | - | - | Upgrade |
Accrued Expenses | - | 3.15 | 1.85 | 0.1 | 8.8 | Upgrade |
Current Portion of Long-Term Debt | 81.64 | 75.26 | 65.55 | - | - | Upgrade |
Current Income Taxes Payable | - | 2.19 | 0.68 | - | - | Upgrade |
Other Current Liabilities | 15.11 | 0.58 | 3.04 | - | 2.79 | Upgrade |
Total Current Liabilities | 140.32 | 122.36 | 73.49 | 0.1 | 11.59 | Upgrade |
Long-Term Debt | 89.91 | 46.75 | 76.47 | - | 14.52 | Upgrade |
Long-Term Deferred Tax Liabilities | 0.74 | 0.8 | 0.45 | - | - | Upgrade |
Other Long-Term Liabilities | - | 0 | -0 | - | 9.68 | Upgrade |
Total Liabilities | 230.97 | 169.91 | 150.41 | 0.1 | 35.79 | Upgrade |
Common Stock | 120 | 120 | 30 | 30 | 22.77 | Upgrade |
Retained Earnings | 6.52 | 2.8 | 0.83 | -0.1 | -56.59 | Upgrade |
Comprehensive Income & Other | - | - | - | - | 10.64 | Upgrade |
Total Common Equity | 126.52 | 122.8 | 30.83 | 29.9 | -23.18 | Upgrade |
Minority Interest | 31.68 | 27.86 | 20.5 | - | - | Upgrade |
Shareholders' Equity | 158.2 | 150.66 | 51.33 | 29.9 | -23.18 | Upgrade |
Total Liabilities & Equity | 389.18 | 320.57 | 201.74 | 30 | 12.61 | Upgrade |
Total Debt | 171.55 | 122.02 | 142.03 | - | 14.52 | Upgrade |
Net Cash (Debt) | -170.36 | -121.6 | -140.46 | 20.83 | -14.52 | Upgrade |
Net Cash Per Share | -14.23 | -10.13 | -46.82 | 6.94 | -6.38 | Upgrade |
Filing Date Shares Outstanding | 11.55 | 12 | 3 | 3 | 2.28 | Upgrade |
Total Common Shares Outstanding | 11.55 | 12 | 3 | 3 | 2.28 | Upgrade |
Working Capital | 168.49 | 138.29 | 77.11 | 29.9 | -3.94 | Upgrade |
Book Value Per Share | 10.95 | 10.23 | 10.28 | 9.97 | -10.18 | Upgrade |
Tangible Book Value | 126.52 | 122.8 | 30.83 | 29.9 | -23.22 | Upgrade |
Tangible Book Value Per Share | 10.95 | 10.23 | 10.28 | 9.97 | -10.20 | Upgrade |
Machinery | - | - | - | - | 1.01 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.